Sine Aid Peak Misery Spray
NDC Package 62372-100-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Sine Aid Peak Misery (oxymetazoline hydrochloride) sprays is uses • temporarily relieves nasal congestoin reduces swelling of nasal passageshelps decongest sinus openings and passagestemporarily relives sinus congestion and pressurepromotes sinus drainageshrinks swollen nasal membranes so you can temporarily breathe more freely. This formulation utilizes a spray delivery system. Marketed by Infirst Healthcare Inc., this product is identified by NDC 62372-100 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
62372-100-30
Package Description
30 mL in 1 BOTTLE, SPRAY
Product Code
62372-100
11-Digit Billing Format
62372010030

Clinical Specifications

Proprietary Name
Sine Aid Peak Misery
Non-Proprietary Name
Oxymetazoline Hydrochloride
Substance Name
Oxymetazoline Hydrochloride
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Nasal - Administration to the nose; administered by way of the nose.
Active Ingredient(s)
OXYMETAZOLINE HYDROCHLORIDE .05 g/100mL
Pharmacologic Class
Usage Information
Uses • temporarily relieves nasal congestoin reduces swelling of nasal passageshelps decongest sinus openings and passagestemporarily relives sinus congestion and pressurepromotes sinus drainageshrinks swollen nasal membranes so you can temporarily breathe more freely.

Regulatory & Marketing

Labeler Name
Infirst Healthcare Inc.
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-06-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62372-100-30 identifies a specific commercial package of 30 ml in 1 bottle, spray of Sine Aid Peak Misery, a human over the counter drug labeled by Infirst Healthcare Inc.. This spray is formulated for nasal use and contains oxymetazoline hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Infirst Healthcare Inc. on August 06, 2026. The current certification is valid through December 31, 2027.

How is this Infirst Healthcare Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62372010030. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62372-100-30
11-Digit CMS (5-4-2)
62372-0100-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.